Publications by authors named "Katherine Liming"

Claim this Profile
S
Selpercatinib in Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial.
Oliver Gautschi, Keunchil Park, Benjamin J Solomon, Pascale Tomasini, Herbert H Loong, Katherine Liming

J Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of selpercatinib for Rearranged during transfection (RET)-activated advanced solid tumors in LIBRETTO-001: differing patterns of adverse events over time.
Luis E Raez, Ashish C Massey, Scott S Barker, Patrick M Peterson, Katherine Liming

Oncologist· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis